导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.35% | 19/60 |
| 近一周 | -1.20% | 2/64 |
| 近一月 | -1.42% | 4/64 |
| 近一季 | -0.09% | 20/63 |
| 近半年 | 10.25% | 16/60 |
| 近一年 | 5.14% | 20/54 |
| 近两年 | 35.96% | 30/49 |
| 近三年 | 45.88% | 17/38 |
| 成立以来 | 370.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.79% 76/109 |
10.17% 51/119 |
- - |
- - |
| 2025 | 19.57% 77/108 |
0.38% 68/97 |
7.82% 63/99 |
13.41% 72/104 |
-2.58% 47/108 |
| 2024 | 14.46% 42/97 |
5.26% 31/89 |
5.83% 30/94 |
2.32% 73/97 |
0.42% 42/97 |
| 2023 | 6.84% 21/93 |
4.17% 22/73 |
5.35% 18/77 |
-5.63% 63/82 |
3.16% 35/93 |
| 2022 | -10.42% 10/71 |
-10.17% 10/58 |
-0.23% 45/62 |
-7.11% 8/68 |
7.61% 25/71 |
| 2021 | 2.71% 11/58 |
1.98% 140/312 |
8.66% 88/328 |
-5.05% 184/358 |
-2.39% 13/58 |
| 2020 | 23.73% 24/38 |
-12.97% 159/280 |
18.04% 114/295 |
5.49% 91/299 |
14.18% 64/305 |
| 2019 | 24.99% 15/30 |
9.45% 135/258 |
5.03% 36/268 |
2.02% 91/253 |
6.57% 130/266 |
| 2018 | -4.57% 1/28 |
- - |
- - |
- - |
-10.81% 121/241 |
| 2017 | 19.20% 15/20 |
- - |
- - |
- - |
- - |
| 2016 | 7.10% 6/17 |
- - |
- - |
- - |
- - |
| 2015 | 0.21% 3/16 |
- - |
- - |
- - |
- - |
| 2014 | 6.40% 38/99 |
- - |
- - |
- - |
- - |
| 2013 | 20.02% 12/70 |
- - |
- - |
- - |
- - |
| 2012 | 15.61% 12/51 |
- - |
- - |
- - |
- - |
| 2011 | -23.91% 23/27 |
- - |
- - |
- - |
- - |
| 2010 | 1.46% 6/9 |
- - |
- - |
- - |
- - |
| 2009 | 72.18% 2/9 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 摩根中国生物医药混合(QDII)A | 1.4779 | 17.64% |
| 摩根中国生物医药混合(QDII)C | 1.4554 | 17.49% |
| 南方港股医药行业混合发起(QDII)A | 1.3423 | 15.29% |
| 南方港股医药行业混合发起(QDII)C | 1.2936 | 15.12% |
| 东方红医疗创新混合(QDII)A | 0.8769 | 15.09% |
| 东方红医疗创新混合(QDII)C | 0.8725 | 13.42% |
| 万家全球成长一年持有期混合(QDII)A | 0.9681 | 12.64% |
| 万家全球成长一年持有期混合(QDII)C | 0.9395 | 12.46% |
| 长城港股医疗保健精选混合发起(QDII)A | 0.7593 | 8.70% |
| 富国医药精选混合(QDII)A | 0.9730 | 8.69% |
| 交银环球精选混合(QDII) VS. 建信新兴市场混合(QDII)A(539002) |